Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesBiotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...